Venzon D - Search Results

1

Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer.

Hamada A, Danesi R, Price DK, Sissung T, Chau C, Venzon D, Sparreboom A, Dahut WL, Figg WD. Hamada A, et al. Among authors: venzon d. Urology. 2007 Aug;70(2):217-20. doi: 10.1016/j.urology.2007.06.1097. Urology. 2007. PMID: 17826473 Free PMC article.

2

Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.

Bitton RJ, Figg WD, Venzon DJ, Dalakas MC, Bowden C, Headlee D, Reed E, Myers CE, Cooper MR. Bitton RJ, et al. Among authors: venzon dj. J Clin Oncol. 1995 Sep;13(9):2223-9. doi: 10.1200/JCO.1995.13.9.2223. J Clin Oncol. 1995. PMID: 7666080 Clinical Trial.

3

Phase I study of phenylacetate administered twice daily to patients with cancer.

Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE. Thibault A, et al. Among authors: venzon dj. Cancer. 1995 Jun 15;75(12):2932-8. doi: 10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p. Cancer. 1995. PMID: 7773944 Clinical Trial.

4

Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.

Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, de la Rosa A, MacDonald NJ, Steeg PS, Linehan WM. Walther MM, et al. Among authors: venzon d. J Urol. 1995 Jul;154(1):278-82. J Urol. 1995. PMID: 7776445

5

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins AC, Weinberger MS, Headlee DJ, McCall NA, Samid D, et al. Thibault A, et al. Among authors: venzon dj. Cancer Res. 1994 Apr 1;54(7):1690-4. Cancer Res. 1994. PMID: 8137283 Clinical Trial.

6

In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3.

Dixon SC, Zalles A, Giordano C, Lush RM, Venzon D, Reed E, Figg WD. Dixon SC, et al. Among authors: venzon d. Cancer Lett. 1997 Feb 26;113(1-2):111-6. doi: 10.1016/s0304-3835(97)04603-x. Cancer Lett. 1997. PMID: 9065809

7

Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival.

Walther MM, Kleiner DE, Lubensky IA, Pozzatti R, Nyguen T, Gnarra JR, Hurley K, Venzon D, Linehan WM, Stetler-Stevenson WG. Walther MM, et al. Among authors: venzon d. Urology. 1997 Aug;50(2):295-301. doi: 10.1016/s0090-4295(97)00220-3. Urology. 1997. PMID: 9255309

8

Hypercalcemia in patients with metastatic renal cell carcinoma: effect of nephrectomy and metabolic evaluation.

Walther MM, Patel B, Choyke PL, Lubensky IA, Vocke CD, Harris C, Venzon D, Burtis WJ, Linehan WM. Walther MM, et al. Among authors: venzon d. J Urol. 1997 Sep;158(3 Pt 1):733-9. doi: 10.1097/00005392-199709000-00011. J Urol. 1997. PMID: 9258070

9

Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival.

Walther MM, Johnson B, Culley D, Shah R, Weber J, Venzon D, Yang JC, Linehan WM, Rosenberg SA. Walther MM, et al. Among authors: venzon d. J Urol. 1998 Mar;159(3):718-22. J Urol. 1998. PMID: 9474133

10

Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer.

Feuer JA, Lush RM, Venzon D, Duray P, Tompkins A, Sartor O, Figg WD. Feuer JA, et al. Among authors: venzon d. J Investig Med. 1998 Feb;46(2):66-72. J Investig Med. 1998. PMID: 9549229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters